Results 161 to 170 of about 2,911,119 (244)

Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care. [PDF]

JCO Precis Oncol
Bokemeyer C, Abrams KR, Garcia-Foncillas J, Italiano A, Lassen U, Linsell L, Marian M, Paracha N, Sullivan SD, Brega N, Thompson J.   +10 more
europepmc   +1 more source

Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo. [PDF]

Cancer Biol Ther, 2015
Li Z, Zhang Y, Tong Y, Tong J, Thiele CJ.   +4 more
europepmc   +1 more source

Extraskeletal osteosarcoma harboring ETV6::NTRK3 fusion treated successfully with larotrectinib: a case study. [PDF]

Commun Med (Lond)
Skok K, Ochsenhofer F, Gassner R, Leithner A, Szkandera J, Viertler C, Hasenschwandtner S, Reichinger A, Liegl-Atzwanger B.   +8 more
europepmc   +1 more source

Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib. [PDF]

Thorac Cancer
Avancini A, Sposito M, Adamoli G, Borsati A, Ciurnelli C, Scaglione IM, Eccher S, Toniolo L, Tregnago D, Longo L, Insolda J, Milella M, Schena F, Pilotto S, Belluomini L.   +14 more
europepmc   +1 more source

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion. [PDF]

Oncologist
Akrout F, Bogumil H, Yedeas MD, Sievers P, Touat M, Achoura S.   +5 more
europepmc   +1 more source

Neurotrophic factors as double-edged swords in osteosarcoma: drivers of tumour growth and immune remodelling. [PDF]

Front Immunol
Lei P, Li L.
europepmc   +1 more source

Advances in Tissue-Agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. [PDF]

Oncol Res
Rubinstein M, Hong ML, Nanda RK, Jones DT, Aboaid H, Myat YM, Thein KZ.   +6 more
europepmc   +1 more source

TPM3-NTRK1 Fusion Cervical Sarcoma: A Case Report of a Novel Subset of Gynaecological Sarcomas and Successful Treatment of Recurrent Disease With Trk-Inhibition Therapy. [PDF]

Cureus
Lowe-Zinola J, Elghobashy M, Evans M, Hafeez T, El-Ghobashy A.   +4 more
europepmc   +1 more source